118 related articles for article (PubMed ID: 37977290)
41. Engineering Core-Shell Structures of Magnetic Ferrite Nanoparticles for High Hyperthermia Performance.
Darwish MSA; Kim H; Lee H; Ryu C; Young Lee J; Yoon J
Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32455690
[TBL] [Abstract][Full Text] [Related]
42. Potential of novel electrospun core-shell structured polyurethane/starch (hyaluronic acid) nanofibers for skin tissue engineering: In vitro and in vivo evaluation.
Movahedi M; Asefnejad A; Rafienia M; Khorasani MT
Int J Biol Macromol; 2020 Mar; 146():627-637. PubMed ID: 31805327
[TBL] [Abstract][Full Text] [Related]
43. Controlled Release of Metformin Hydrochloride from Core-Shell Nanofibers with Fish Sarcoplasmic Protein.
Sena S; Sumeyra KN; Ulkugul G; Sema A; Betul K; Muge SB; Sayip EM; Muhammet U; Cevriye K; Mahir M; Titu MA; Ficai D; Ficai A; Gunduz O
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31658758
[No Abstract] [Full Text] [Related]
44. Biocompatible, Multi-Mode, Fluorescent,
Waters M; Hopf J; Tam E; Wallace S; Chang J; Bennett Z; Aquino H; Roeder RK; Helquist P; Stack MS; Nallathamby PD
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297329
[TBL] [Abstract][Full Text] [Related]
45. SiO
Dai Z; Wen W; Guo Z; Song XZ; Zheng K; Xu X; Qi X; Tan Z
Colloids Surf B Biointerfaces; 2020 Nov; 195():111274. PubMed ID: 32739773
[TBL] [Abstract][Full Text] [Related]
46. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
[TBL] [Abstract][Full Text] [Related]
47. Dual-drug delivery of Ag-chitosan nanoparticles and phenytoin via core-shell PVA/PCL electrospun nanofibers.
Mohamady Hussein MA; Guler E; Rayaman E; Cam ME; Sahin A; Grinholc M; Sezgin Mansuroglu D; Sahin YM; Gunduz O; Muhammed M; El-Sherbiny IM; Megahed M
Carbohydr Polym; 2021 Oct; 270():118373. PubMed ID: 34364617
[TBL] [Abstract][Full Text] [Related]
48. A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication.
Gao W; Zheng Y; Wang R; Chen H; Cai X; Lu G; Chu L; Xu C; Zhang N; Wang Z; Ran H; Li P; Yang C; Mei Z; Song J
Acta Biomater; 2016 Jan; 29():298-306. PubMed ID: 26432438
[TBL] [Abstract][Full Text] [Related]
49. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
Small; 2017 Jan; 13(2):. PubMed ID: 27735129
[TBL] [Abstract][Full Text] [Related]
50. Coaxial electrospun angiogenic nanofiber wound dressing containing advanced platelet rich-fibrin.
Tavakoli M; Mirhaj M; Salehi S; Varshosaz J; Labbaf S; Golshirazi A; Kazemi N; Haghighi V
Int J Biol Macromol; 2022 Dec; 222(Pt A):1605-1618. PubMed ID: 36116591
[TBL] [Abstract][Full Text] [Related]
51. Glutaraldehyde crosslinked doxorubicin promotes drug delivery efficiency using cobalt ferrite nanoparticles.
Vajhadin F; Mazloum-Ardakani M; Raeisi S; Hemati M; Ebadi A; Haghiralsadat F; Tofighi D
Colloids Surf B Biointerfaces; 2022 Dec; 220():112870. PubMed ID: 36283186
[TBL] [Abstract][Full Text] [Related]
52. Magnetic field-inducible drug-eluting nanoparticles for image-guided thermo-chemotherapy.
Thirunavukkarasu GK; Cherukula K; Lee H; Jeong YY; Park IK; Lee JY
Biomaterials; 2018 Oct; 180():240-252. PubMed ID: 30055399
[TBL] [Abstract][Full Text] [Related]
53. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
[TBL] [Abstract][Full Text] [Related]
54. Catechol-metal coordination-mediated nanocomposite hydrogels for on-demand drug delivery and efficacious combination therapy.
Dai G; Sun L; Xu J; Zhao G; Tan Z; Wang C; Sun X; Xu K; Zhong W
Acta Biomater; 2021 Jul; 129():84-95. PubMed ID: 34010690
[TBL] [Abstract][Full Text] [Related]
55. Controlled Release of Ciprofloxacin from Core-Shell Nanofibers with Monolithic or Blended Core.
Zupančič Š; Sinha-Ray S; Sinha-Ray S; Kristl J; Yarin AL
Mol Pharm; 2016 Apr; 13(4):1393-404. PubMed ID: 26950163
[TBL] [Abstract][Full Text] [Related]
56. Co-loading of doxorubicin and iron oxide nanocubes in polycaprolactone fibers for combining Magneto-Thermal and chemotherapeutic effects on cancer cells.
Serio F; Silvestri N; Kumar Avugadda S; Nucci GEP; Nitti S; Onesto V; Catalano F; D'Amone E; Gigli G; Del Mercato LL; Pellegrino T
J Colloid Interface Sci; 2022 Feb; 607(Pt 1):34-44. PubMed ID: 34492351
[TBL] [Abstract][Full Text] [Related]
57. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells.
Lee H; Kim S; Choi BH; Park MT; Lee J; Jeong SY; Choi EK; Lim BU; Kim C; Park HJ
Int J Hyperthermia; 2011; 27(7):698-707. PubMed ID: 21992562
[TBL] [Abstract][Full Text] [Related]
58. Drug-loaded liposome-capped mesoporous core-shell magnetic nanoparticles for cellular toxicity study.
Sharifabad ME; Mercer T; Sen T
Nanomedicine (Lond); 2016 Nov; 11(21):2757-2767. PubMed ID: 27759497
[TBL] [Abstract][Full Text] [Related]
59. Sequential Delivery of Doxorubicin and Zoledronic Acid to Breast Cancer Cells by CB[7]-Modified Iron Oxide Nanoparticles.
Benyettou F; Alhashimi M; O'Connor M; Pasricha R; Brandel J; Traboulsi H; Mazher J; Olsen JC; Trabolsi A
ACS Appl Mater Interfaces; 2017 Nov; 9(46):40006-40016. PubMed ID: 29035507
[TBL] [Abstract][Full Text] [Related]
60. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
